While current evidence supports its association with incident CVD, atherosclerotic burden, and adverse outcomes, further prospective, multiethnic studies are needed to define optimal thresholds, clarify its role alongside existing risk models, and determine whether TyG-guided strategies can improve clinical outcomes.
M. Cherska, Khrystyna Kukharchuk, A. Ceasovschih et al.· Lipids in Health and Disease· 0 citations
Cardiovascular–kidney–metabolic (CKM) syndrome is driven by the interplay of visceral adiposity, insulin resistance, chronic inflammation, oxidative stress, and progressive kidney dysfunction. These mechanisms generate a distinct atherogenic dyslipidaemic phenotype characterised by elevated triglycerides (TG), reduced...
A. Ceasovschih, Y. Şener, M. Arıcı et al.· International Journal of Mol...· 0 citations
The gender and age-related differences in the rates of awareness, treatment involvement and BP control were revealed and those on antihypertensive medication were revealed.
L. Mishchenko, T. Chendey, M. Cherska et al.· European Heart Journal, Supp...· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.